Trial intelligence / Profile preview

Immune Responses to LAIV vs TIV in Preterm and Full-Term Infants

NCT01194297Phase 4Terminated

Sponsor
University of Rochester
Start
Aug 2010
Primary completion
May 2012
Modality
Vaccines & Immunotherapeutics
01

Overview

A Phase 4 trial of live attenuated influenza vaccine in influenza, sponsored by University of Rochester. Started Aug 2010; status: terminated.

02

Drugs

live attenuated influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NCT01194297.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01194297.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call